Abacavir Infectious Diseases HLA-B Boxed Warning, Dosage and Administration, Contraindications, Warnings and Precautions Abemaciclib (1) Oncology ESR
(Hormone Receptor) Indications and Usage, Adverse Reactions, Clinical Studies Abemaciclib (2) Oncology ERBB2
(HER2) Indications and Usage, Adverse Reactions, Clinical Studies Abemaciclib (3) Oncology MKI67 Clinical Studies Abrocitinib Dermatology CYP2C19 Dosage and Administration, Use in Specific Populations, Clinical Pharmacology Adagrasib Oncology KRAS Indications and Usage, Dosage and Administration, Adverse Reactions, Clinical Pharmacology, Clinical Studies Ado-Trastuzumab Emtansine Oncology ERBB2
(HER2) Indications and Usage, Dosage and Administration, Adverse Reactions, Clinical Pharmacology, Clinical Studies Aducanumab-avwa Neurology APOE Boxed Warning, Warnings and Precautions, Clinical Studies, Patient Counseling Information Afatinib Oncology EGFR Indications and Usage, Dosage and Administration, Adverse Reactions, Clinical Studies Alectinib Oncology ALK Indications and Usage, Dosage and Administration, Adverse Reactions, Clinical Pharmacology, Clinical Studies Alglucosidase Alfa Inborn Errors of Metabolism GAA Warnings and Precautions Allopurinol Oncology HLA-B Warnings Alpelisib (1) Oncology ERBB2
(HER2) Indication and Usage, Dosage and Administration, Adverse Reactions, Clinical Studies Alpelisib (2) Oncology ESR
(Hormone Receptor) Indication and Usage, Dosage and Administration, Adverse Reactions, Clinical Studies Alpelisib (3) Oncology PIK3CA Indication and Usage, Dosage and Administration, Adverse Reactions, Clinical Studies Amifampridine Phosphate Neurology NAT2 Dosage and Administration, Use in Specific Populations, Clinical Pharmacology Amikacin Infectious Diseases   MT-RNR1   Warnings and Precautions Amitriptyline Psychiatry CYP2D6 Precautions Amivantamab-vmjw Oncology EGFR Indications and Usage, Dosage and Administration, Adverse Reactions, Clinical Studies Amoxapine Psychiatry CYP2D6 Precautions Amphetamine Psychiatry CYP2D6 Clinical Pharmacology Anakinra Rheumatology NLRP3 Indications and Usage, Dosage and Administration, Warnings and Precautions, Adverse Reactions, Use in Specific Populations, Clinical Pharmacology, Clinical Studies Anastrozole Oncology ESR, PGR
(Hormone Receptor) Indications and Usage, Adverse Reactions, Drug Interactions, Clinical Studies Anifrolumab-fnia Rheumatology Gene Signature
(IFN) Clinical Pharmacology, Clinical Studies Arformoterol (1) Pulmonary UGT1A1 Clinical Pharmacology Arformoterol (2) Pulmonary CYP2D6 Clinical Pharmacology Aripiprazole Psychiatry CYP2D6 Dosage and Administration, Use in Specific Populations, Clinical Pharmacology Aripiprazole Lauroxil Psychiatry CYP2D6 Dosage and Administration, Use in Specific Populations, Clinical Pharmacology Arsenic Trioxide Oncology PML-RARA Indications and Usage, Clinical Studies Articaine and Epinephrine (1) Anesthesiology G6PD Warnings and Precautions Articaine and Epinephrine (2) Anesthesiology Nonspecific
(Congenital Methemoglobinemia) Warnings and Precautions Asciminib Oncology BCR-ABL1
(Philadelphia chromosome) Indications and Usage, Dosage and Administration, Adverse Reactions, Use in Specific Populations, Clinical Studies Ascorbic Acid Endocrinology G6PD Dosage and Administration, Warnings and Precautions, Adverse Reactions, Patient Counseling Information Atezolizumab (1) Oncology CD274
(PD-L1) Indications and Usage, Dosage and Administration, Adverse Reactions, Clinical Pharmacology, Clinical Studies Atezolizumab (2)   Oncology Gene Signature
(T-effector) Clinical Studies Atezolizumab (3) Oncology EGFR Indications and Usage, Adverse Reactions, Clinical Studies Atezolizumab (4) Oncology ALK Indications and Usage, Adverse Reactions, Clinical Studies Atezolizumab (5) Oncology BRAF Indications and Usage, Dosage and Administration, Adverse Reactions, Clinical Studies Atomoxetine Psychiatry CYP2D6 Dosage and Administration, Warnings and Precautions, Adverse Reactions, Drug Interactions, Use in Specific Populations, Clinical Pharmacology Ascorbic Acid, PEG-3350, Potassium Chloride, Sodium Ascorbate, Sodium Chloride, and Sodium Sulfate Gastroenterology G6PD Warnings and Precautions, Adverse Reactions Avapritinib (1) Oncology PDGFRA Indications and Usage, Dosage and Administration, Clinical Studies Avapritinib (2) Oncology KIT Clinical Studies Avatrombopag (1) Hematology F2
(Prothrombin) Warnings and Precautions Avatrombopag (2) Hematology F5
(Factor V Leiden) Warnings and Precautions Avatrombopag (3) Hematology PROC Warnings and Precautions Avatrombopag (4) Hematology PROS1 Warnings and Precautions Avatrombopag (5) Hematology SERPINC1
(Antithrombin III) Warnings and Precautions Avatrombopag (6) Hematology CYP2C9 Clinical Pharmacology Avelumab Oncology CD274
(PD-L1) Clinical Studies Azacitidine (1) Oncology CBL Clinical Studies Azacitidine (2) Oncology PTPN11 Clinical Studies Azacitidine (3) Oncology RAS Clinical Studies Azathioprine (1) Rheumatology TPMT Dosage and Administration, Warnings, Precautions, Drug Interactions, Adverse Reactions, Clinical Pharmacology Azathioprine (2) Rheumatology NUDT15 Dosage and Administration, Warnings, Precautions, Adverse Reactions, Clinical Pharmacology Belinostat Oncology UGT1A1 Dosage and Administration, Clinical Pharmacology Belzutifan (1) Oncology CYP2C19 Warnings and Precautions, Drug Interactions, Use in Specific Populations, Clinical Pharmacology Belzutifan (2) Oncology UGT2B17 Warnings and Precautions, Drug Interactions, Use in Specific Populations, Clinical Pharmacology Belzutifan (3) Oncology VHL Clinical Studies Bempedoic Acid and Ezetimibe Endocrinology Nonspecific
(Heterozygous Familial Hypercholesterolemia) Indications and Usage, Adverse Reactions, Clinical Studies Betaine Inborn Errors of Metabolism CBS, MMADHC, MTHFR (Homocystinuria Deficiency) Indications and Usage, Warnings and Precautions, Clinical Pharmacology, Clinical Studies Binimetinib (1) Oncology BRAF Indications and Usage, Adverse Reactions, Use in Specific Populations, Clinical Pharmacology, Clinical Studies Binimetinib (2) Oncology UGT1A1 Indications and Usage, Use in Specific Populations Blinatumomab (1) Oncology BCR-ABL1
(Philadelphia chromosome) Indications and Usage, Adverse Reactions, Use in Specific Populations, Clinical Pharmacology, Clinical Studies Blinatumomab (2) Oncology CD19 Indications and Usage, Use in Specific Populations Boceprevir Infectious Diseases IFNL3
(IL28B) Clinical Pharmacology Bosutinib Oncology BCR-ABL1
(Philadelphia chromosome) Indications and Usage, Dosage and Administration, Warnings and Precautions, Adverse Reactions, Use in Specific Populations, Clinical Studies Brentuximab Vedotin (1) Oncology ALK Use in Specific Populations, Clinical Studies Brentuximab Vedotin (2) Oncology TNFRSF8
(CD30) Indications and Usage, Dosage and Administration, Adverse Reactions, Use in Specific Populations, Clinical Studies Brexpiprazole Psychiatry CYP2D6 Dosage and Administration, Use in Specific Populations, Clinical Pharmacology Brigatinib Oncology ALK Indications and Usage, Dosage and Administration, Adverse Reactions, Clinical Studies Brivaracetam Neurology CYP2C19 Clinical Pharmacology Bupivacaine (1) Anesthesiology G6PD Warnings Bupivacaine (2) Anesthesiology Nonspecific
(Congenital Methemoglobinemia) Warnings Bupropion Psychiatry CYP2D6 Clinical Pharmacology Bupropion and Dextromethorphan Psychiatry CYP2D6 Dosage and Administration, Use in Specific Populations, Clinical Pharmacology Busulfan Oncology BCR-ABL1
(Philadelphia chromosome) Clinical Studies Cabotegravir and Rilpivirine (1) Infectious Diseases HLA-B Clinical Studies Cabotegravir and Rilpivirine (2) Infectious Diseases UGT1A1 Clinical Pharmacology Cabozantinib Oncology RET Clinical Studies Capmatinib Oncology MET Indications and Usage, Dosage and Administration, Clinical Studies Capecitabine (1) Oncology DPYD Warnings and Precautions, Clinical Pharmacology, Patient Counseling Information Capecitabine (2) Oncology ERBB2
(HER2) Indications and Usage, Dosage and Administration, Adverse Reactions, Clinical Studies Capivasertib (1) Oncology AKT1 Indications and Usage, Dosage and Administration, Adverse Reactions, Clinical Studies Capivasertib (2) Oncology ERBB2
(HER2) Indications and Usage, Dosage and Administration, Clinical Studies Capivasertib (3) Oncology ESR
(Hormone Receptor) Indications and Usage, Dosage and Administration, Clinical Studies Capivasertib (4) Oncology PIK3CA Indications and Usage, Dosage and Administration, Adverse Reactions, Clinical Studies Capivasertib (5) Oncology PTEN Indications and Usage, Dosage and Administration, Adverse Reactions, Clinical Studies Carbamazepine (1) Neurology HLA-B Boxed Warning, Warnings, Precautions Carbamazepine (2) Neurology HLA-A Warnings Carglumic Acid Inborn Errors of Metabolism NAGS Indications and Usage, Dosage and Administration, Warnings and Precautions, Use in Specific Populations, Clinical Pharmacology, Clinical Studies Cariprazine Psychiatry CYP2D6 Clinical Pharmacology Carisoprodol Rheumatology CYP2C19 Use in Specific Populations, Clinical Pharmacology Carvedilol Cardiology CYP2D6 Drug Interactions, Clinical Pharmacology Casimersen Neurology DMD Indications and Usage, Adverse Reactions, Use in Specific Populations, Clinical Pharmacology, Clinical Studies Ceftriaxone (1) Infectious Diseases G6PD Warnings Ceftriaxone (2) Infectious Diseases Nonspecific
(Congenital Methemoglobinemia) Warnings Celecoxib Rheumatology CYP2C9 Dosage and Administration, Use in Specific Populations, Clinical Pharmacology Cemiplimab-rwlc (1) Oncology ALK Indications and Usage, Clinical Studies Cemiplimab-rwlc (2) Oncology CD274
(PD-L1) Indications and Usage, Dosage and Administration, Clinical Studies Cemiplimab-rwlc (3) Oncology EGFR Indications and Usage, Clinical Studies Cemiplimab-rwlc (4) Oncology ROS1 Indications and Usage, Clinical Studies Ceritinib Oncology ALK Indications and Usage, Dosage and Administration, Warning and Precautions, Adverse Reactions, Clinical Studies Cerliponase Alfa Inborn Errors of Metabolism TPP1 Indications and Usage, Use in Specific Populations, Clinical Studies Cetuximab (1) Oncology EGFR Indications and Usage, Dosage and Administration, Adverse Reactions, Clinical Studies Cetuximab (2) Oncology RAS Indications and Usage, Dosage and Administration, Warnings and Precautions, Adverse Reactions, Clinical Studies Cetuximab (3) Oncology BRAF Indications and Usage, Dosage and Administration, Adverse Reactions, Use in Specific Populations, Clinical Studies Cevimeline Dental CYP2D6 Precautions Chloroprocaine (1) Anesthesiology G6PD Warnings Chloroprocaine (2) Anesthesiology Nonspecific
(Congenital Methemoglobinemia) Warnings Chloroquine Infectious Diseases G6PD Precautions, Adverse Reactions Chlorpropamide Endocrinology G6PD Precautions Cholic Acid Inborn Errors of Metabolism AMACR, AKR1D1, CYP7A1, CYP27A1, DHCR7, HSD3B2
(Bile Acid Synthesis Disorders) Indications and Usage, Dosage and Administration, Warnings and Precautions, Adverse Reactions, Use in Specific Populations, Clinical Studies Cisplatin Oncology TPMT Adverse Reactions Citalopram (1) Psychiatry CYP2C19 Dosage and Administration, Warnings, Clinical Pharmacology Citalopram (2) Psychiatry CYP2D6 Clinical Pharmacology Clobazam Neurology CYP2C19 Dosage and Administration, Use in Specific Populations, Clinical Pharmacology Clomipramine Psychiatry CYP2D6 Precautions Clopidogrel Cardiology CYP2C19 Boxed Warning, Warnings and Precautions, Clinical Pharmacology Clozapine Psychiatry CYP2D6 Dosage and Administration, Use in Specific Populations, Clinical Pharmacology Cobimetinib Oncology BRAF Indications and Usage, Dosage and Administration, Adverse Reactions, Clinical Studies Codeine Anesthesiology CYP2D6 Boxed Warning, Warnings and Precautions, Use in Specific Populations, Patient Counseling Information Crizanlizumab-tmca Hematology HBB Adverse Reactions, Clinical Studies Crizotinib (1) Oncology ALK Indications and Usage, Dosage and Administration, Adverse Reactions, Use in Specific Populations, Clinical Pharmacology, Clinical Studies Crizotinib (2) Oncology ROS1 Indications and Usage, Dosage and Administration, Adverse Reactions, Use in Specific Populations, Clinical Studies Dabrafenib (1) Oncology BRAF Indications and Usage, Dosage and Administration, Warnings and Precautions, Adverse Reactions, Use in Specific Populations, Clinical Pharmacology, Clinical Studies Dabrafenib (2) Oncology G6PD Warnings and Precautions, Adverse Reactions, Patient Counseling Information Dabrafenib (3) Oncology RAS Dosage and Administration, Warnings and Precautions Daclatasvir Infectious Diseases IFNL3
(IL28B) Clinical Studies Dacomitinib Oncology EGFR Indications and Usage, Dosage and Administration, Adverse Reactions, Use in Specific Populations, Clinical Studies Dapsone (1) Dermatology G6PD Warnings and Precautions, Use in Specific Populations, Patient Counseling Information Dapsone (2) Dermatology Nonspecific
(Congenital Methemoglobinemia) Warnings and Precautions, Adverse Reactions, Patient Counseling Information Dapsone (3) Infectious Diseases G6PD Precautions, Adverse Reactions, Overdosage Darifenacin Urology CYP2D6 Clinical Pharmacology Dasabuvir, Ombitasvir, Paritaprevir, and Ritonavir Infectious Diseases IFNL3
(IL28B) Clinical Studies Dasatinib Oncology BCR-ABL1
(Philadelphia chromosome) Indications and Usage, Dosage and Administration, Warnings and Precautions, Adverse Reactions, Use in Specific Populations, Clinical Studies Denileukin Diftitox Oncology IL2RA
(CD25 antigen) Indications and Usage, Clinical Studies Desipramine Psychiatry CYP2D6 Precautions Desflurane Anesthesiology CACNA1S, RYR1
(Genetic Susceptibility to Malignant Hyperthermia) Contraindications, Warnings and Precautions, Clinical Pharmacology Desmopressin Hematology F8 Indications and Usage, Dosage and Administration, Clinical Pharmacology Desvenlafaxine Psychiatry CYP2D6 Clinical Pharmacology Deutetrabenazine Neurology CYP2D6 Dosage and Administration, Use in Specific Populations, Clinical Pharmacology Dexlansoprazole Gastroenterology CYP2C19 Drug Interactions, Clinical Pharmacology Dextromethorphan and Quinidine Neurology CYP2D6 Warnings and Precautions, Clinical Pharmacology Diazepam Neurology CYP2C19 Clinical Pharmacology Dinutuximab Oncology MYCN Clinical Studies Docetaxel Oncology ESR, PGR
(Hormone Receptor) Clinical Studies Dolutegravir Infectious Diseases UGT1A1 Clinical Pharmacology Donepezil Neurology CYP2D6 Clinical Pharmacology Dostarlimab-gxly Oncology Microsatellite Instability, Mismatch Repair Indications and Usage, Dosage and Administration, Adverse Reactions, Clinical Studies Doxepin (1) Psychiatry CYP2D6 Clinical Pharmacology Doxepin (2) Psychiatry CYP2C19 Clinical Pharmacology Dronabinol Gastroenterology CYP2C9 Use in Specific Populations, Clinical Pharmacology Drospirenone and Ethinyl Estradiol Gynecology CYP2C19 Clinical Pharmacology Duloxetine Psychiatry CYP2D6 Drug Interactions Durvalumab (1) Oncology   ALK Indications and Usage, Clinical Studies Durvalumab (2) Oncology EGFR Indications and Usage, Clinical Studies Durvalumab (3) Oncology CD274
(PD-L1) Clinical Pharmacology, Clinical Studies Durvalumab (4) Oncology Mismatch Repair Indications and Usage, Dosage and Administration, Adverse Reactions, Clinical Studies Duvelisib Oncology Chromosome 17p Clinical Studies Eculizumab (1) Neurology ACHR Indications and Usage, Clinical Studies Eculizumab (2) Neurology AQP4 Indications and Usage, Clinical Studies Efavirenz Infectious Diseases CYP2B6 Clinical Pharmacology Efgartigimod Alfa-fcab Neurology ACHR Indications and Usage, Clinical Pharmacology, Clinical Studies Eflornithine Oncology MYCN Adverse Reactions, Clinical Studies Elacestrant (1) Oncology   ESR
(Hormone Receptor) Indications and Usage, Dosage and Administration, Adverse Reactions, Clinical Studies Elacestrant (2) Oncology   ERBB2
(HER2) Indications and Usage, Dosage and Administration, Adverse Reactions, Clinical Studies Elagolix Gynecology SLCO1B1 Clinical Pharmacology Elbasvir and Grazoprevir Infectious Diseases IFNL3
(IL28B) Clinical Studies Elexacaftor, Ivacaftor, and Tezacaftor Pulmonary CFTR Indications and Usage, Use in Specific Populations, Clinical Pharmacology, Clinical Studies Eliglustat Inborn Errors of Metabolism CYP2D6 Indications and Usage, Dosage and Administration, Contraindications, Warnings and Precautions, Drug Interactions, Use in Specific Populations, Clinical Pharmacology, Clinical Studies Elranatamab-bcmm (1) Oncology Chromosome 17p Clinical Studies Elranatamab-bcmm (2) Oncology Chromosome 4p;14q Clinical Studies Elranatamab-bcmm (3) Oncology Chromosome 14q;16q Clinical Studies Elosulfase Inborn Errors of Metabolism GALNS Indications and Usage, Warnings and Precautions, Use in Specific Populations, Clinical Pharmacology, Clinical Studies Eltrombopag (1) Hematology F5
(Factor V Leiden) Warnings and Precautions Eltrombopag (2) Hematology SERPINC1
(Antithrombin III) Warnings and Precautions Eltrombopag (3) Hematology Chromosome 7 Adverse Reactions Eltrombopag (4) Hematology Chromosome 13 Adverse Reactions Emapalumab-lzsg Hematology PRF1, RAB27A, SH2D1A, STXBP2, STX11, UNC13D, XIAP (Hemophagocytic Lymphohistiocytosis) Clinical Studies Enasidenib Oncology IDH2 Indications and Usage, Dosage and Administration, Clinical Pharmacology, Clinical Studies Encorafenib (1) Oncology BRAF Indications and Usage, Dosage and Administration, Warnings and Precautions, Adverse Reactions, Use in Specific Populations, Clinical Pharmacology, Clinical Studies, Patient Counseling Information Encorafenib (2) Oncology RAS Dosage and Administration, Warnings and Precautions, Clinical Studies   Entrectinib (1) Oncology ROS1 Indications and Usage, Dosage and Administration, Adverse Reactions, Use in Specific Populations, Clinical Pharmacology, Clinical Studies Entrectinib (2) Oncology NTRK Indications and Usage, Dosage and Administration, Adverse Reactions, Use in Specific Populations, Clinical Pharmacology, Clinical Studies Eplontersen Neurology TTR Adverse Reactions, Clinical Pharmacology, Clinical Studies Erdafitinib (1) Oncology FGFR3 Indications and Usage, Dosage and Administration, Adverse Reactions, Clinical Studies, Patient Counseling Information Erdafitinib (2) Oncology CYP2C9 Use in Specific Populations, Clinical Pharmacology Eribulin (1) Oncology ERBB2
(HER2) Clinical Studies Eribulin (2) Oncology ESR, PGR
(Hormone Receptor) Clinical Studies Erlotinib Oncology EGFR Indications and Usage, Dosage and Administration, Adverse Reactions, Clinical Studies Erythromycin and Sulfisoxazole Infectious Diseases G6PD Precautions Escitalopram (1) Psychiatry CYP2D6 Drug Interactions Escitalopram (2) Psychiatry CYP2C19 Adverse Reactions Esomeprazole Gastroenterology CYP2C19 Drug Interactions, Clinical Pharmacology Estradiol and Progesterone (1) Gynecology PROC Contraindications Estradiol and Progesterone (2) Gynecology PROS1 Contraindications Estradiol and Progesterone (3) Gynecology

SERPINC1
(Antithrombin III)

Contraindications Estradiol Valerate Gynecology ESR, PGR
(Hormone Receptor) Warnings Eteplirsen Neurology DMD Indications and Usage, Adverse Reactions, Use in Specific Populations, Clinical Studies Etrasimod Gastroenterology CYP2C9 Drug Interactions, Use in Specific Populations, Clinical Pharmacology Everolimus (1) Oncology ERBB2
(HER2) Indications and Usage, Dosage and Administration, Warnings and Precautions, Adverse Reactions, Use in Specific Populations, Clinical Pharmacology, Clinical Studies Everolimus (2) Oncology ESR
(Hormone Receptor) Indications and Usage, Dosage and Administration, Warnings and Precautions, Adverse Reactions, Use in Specific Populations, Clinical Pharmacology, Clinical Studies Evinacumab-dgnb (1) Endocrinology LDLR Clinical Studies Evinacumab-dgnb (2) Endocrinology Nonspecific
(Homozygous Familial Hypercholesterolemia) Indication and Usage, Adverse Reactions, Use in Specific Populations, Clinical Pharmacology, Clinical Studies Evolocumab (1) Endocrinology Nonspecific
(Heterozygous Familial Hypercholesterolemia) Indications and Usage, Dosage and Administration, Adverse Reactions, Use in Specific Populations, Clinical Pharmacology, Clinical Studies Evolocumab (2) Endocrinology Nonspecific
(Homozygous Familial Hypercholesterolemia) Indications and Usage, Dosage and Administration, Adverse Reactions, Use in Specific Populations, Clinical Pharmacology, Clinical Studies Exemestane Oncology ESR, PGR
(Hormone Receptor) Indications and Usage, Dosage and Administration, Clinical Studies Fam-Trastuzumab Deruxtecan-nxki (1) Oncology

ERBB2
(HER2)

Indications and Usage, Dosage and Administration, Warnings and Precautions, Adverse Reactions, Use in Specific Populations, Clinical Pharmacology, Clinical Studies

Fam-Trastuzumab Deruxtecan-nxki (2) Oncology ESR
(Hormone Receptor) Clinical Studies Fesoterodine Urology CYP2D6 Drug Interactions, Clinical Pharmacology Fosphenytoin (1) Neurology CYP2C9 Warnings and Precautions, Use in Specific Populations, Clinical Pharmacology Fosphenytoin (2) Neurology HLA-B Warnings and Precautions Flibanserin (1) Gynecology CYP2C9 Clinical Pharmacology Flibanserin (2) Gynecology CYP2C19 Adverse Reactions, Use in Specific Populations, Clinical Pharmacology Flibanserin (3) Gynecology CYP2D6 Clinical Pharmacology Fluorouracil (1) Dermatology DPYD Contraindications, Warnings Fluorouracil (2) Oncology DPYD Warnings and Precautions, Clinical Pharmacology, Patient Counseling Information Fluoxetine Psychiatry CYP2D6 Warnings and Precautions, Drug Interactions, Clinical Pharmacology Flurbiprofen Rheumatology CYP2C9 Clinical Pharmacology Flutamide Oncology G6PD Warnings Fluvoxamine Psychiatry CYP2D6 Drug Interactions Formoterol (1) Pulmonary CYP2D6 Clinical Pharmacology Formoterol (2) Pulmonary CYP2C19 Clinical Pharmacology Fosdenopterin Neurology MOCS1 Indications and Usage, Dosage and Administration, Adverse Reactions, Use in Specific Populations, Clinical Pharmacology, Clinical Studies Fruquintinib Oncology RAS Indications and Usage, Clinical Studies Fulvestrant (1) Oncology ERBB2
(HER2) Indications and Usage, Adverse Reactions, Clinical Studies Fulvestrant (2) Oncology ESR, PGR
(Hormone Receptor) Indications and Usage, Adverse Reactions, Clinical Pharmacology, Clinical Studies Futibatinib Oncology FGFR2 Indications and Usage, Dosage and Administration, Adverse Reactions, Clinical Studies Galantamine Neurology CYP2D6 Clinical Pharmacology Ganaxolone Neurology CDKL5 Indications and Usage, Clinical Studies Gefitinib (1) Oncology EGFR Indications and Usage, Dosage and Administration, Clinical Studies Gefitinib (2) Oncology CYP2D6 Clinical Pharmacology Gemtuzumab Ozogamicin Onoclogy CD33 Indications and Usage, Dosage and Administration, Adverse Reactions, Clinical Studies Gentamicin Infectious Diseases   MT-RNR1   Warnings Gilteritinib Oncology FLT3 Indications and Usage, Dosage and Administration, Clinical Studies Givosiran Gastroenterology CPOX, HMBS, PPOX
(Acute Hepatic Porphyria) Clinical Studies Glimepiride Endocrinology G6PD Warnings and Precautions, Adverse Reactions Glipizide Endocrinology G6PD Precautions Glyburide Endocrinology G6PD Precautions Glycerol Phenylbutyrate (1) Inborn Errors of Metabolism ASS1, CPS1, OTC
(Urea Cycle Disorders) Indications and Usage, Adverse Reactions, Clinical Studies Glycerol Phenylbutyrate (2) Inborn Errors of Metabolism NAGS Indications and Usage Golodirsen Neurology DMD Indications and Usage, Use in Specific Populations, Clinical Pharmacology, Clinical Studies Goserelin Oncology ESR, PGR
(Hormone Receptor) Indications and Usage, Clinical Studies Hydralazine Cardiology Nonspecific
(NAT) Clinical Pharmacology Hydroxychloroquine Infectious Diseases G6PD Warnings and Precautions, Adverse Reactions Ibrutinib (1) Oncology Chromosome 17p Indications and Usage, Clinical Studies Ibrutinib (2) Oncology Chromosome 11q Clinical Studies Ibrutinib (3) Oncology MYD88 Clinical Studies Iloperidone Psychiatry CYP2D6 Dosage and Administration, Warnings and Precautions, Drug Interactions, Clinical Pharmacology Imatinib (1) Oncology KIT Indications and Usage, Dosage and Administration, Clinical Studies Imatinib (2) Oncology BCR-ABL1
(Philadelphia chromosome) Indications and Usage, Dosage and Administration, Warnings and Precautions, Adverse Reactions, Use in Specific Populations, Clinical Pharmacology, Clinical Studies Imatinib (3) Oncology PDGFRB Indications and Usage, Dosage and Administration, Clinical Studies Imatinib (4) Oncology FIP1L1-PDGFRA Indications and Usage, Dosage and Administration, Clinical Studies Imipramine Psychiatry CYP2D6 Precautions Inclisiran Endocrinology Nonspecific
(Heterozygous Familial Hypercholesterolemia) Indications and Usage, Clinical Studies Indacaterol Pulmonary UGT1A1 Clinical Pharmacology Inebilizumab-cdon Neurology AQP4 Indications and Usage, Clinical Studies Inotersen Neurology TTR Adverse Reactions, Clinical Pharmacology Inotuzumab Ozogamicin Oncology BCR-ABL1
(Philadelphia chromosome) Clinical Studies Ipilimumab (1) Oncology HLA-A Clinical Studies Ipilimumab (2) Oncology Microsatellite Instability, Mismatch Repair Indications and Usage, Dosage and Administration, Warnings and Precautions, Adverse Reactions, Use in Specific Populations, Clinical Studies Ipilimumab (3) Oncology CD274
(PD-L1) Indications and Usage, Dosage and Administration, Use in Specific Populations, Clinical Studies Ipilimumab (4) Oncology ALK Indications and Usage, Adverse Reactions, Clinical Studies Ipilimumab (5) Oncology EGFR Indications and Usage, Adverse Reactions, Clinical Studies Irinotecan Oncology UGT1A1 Dosage and Administration, Clinical Pharmacology, Clinical Studies Isatuximab- irfc (1) Oncology Chromosome 17p Clinical Studies Isatuximab- irfc (2) Oncology Chromosome 4p;14q Clinical Studies Isatuximab- irfc (3) Oncology Chromosome 14q;16q Clinical Studies Isoflurane Anesthesiology CACNA1S, RYR1
(Genetic Susceptibility to Malignant Hyperthermia) Contraindications, Warnings, Clinical Pharmacology Isoniazid, Pyrazinamide, and Rifampin Infectious Diseases Nonspecific
(NAT) Clinical Pharmacology Isosorbide Dinitrate Cardiology CYB5R Overdosage Isosorbide Mononitrate Cardiology CYB5R Overdosage Ivacaftor Pulmonary CFTR Indications and Usage, Adverse Reactions, Use in Specific Populations, Clinical Pharmacology, Clinical Studies Ivacaftor and Lumacaftor Pulmonary CFTR Indications and Usage, Adverse Reactions, Use in Specific Populations, Clinical Studies Ivacaftor and Tezacaftor Pulmonary CFTR Indications and Usage, Adverse Reactions, Use in Specific Populations, Clinical Pharmacology, Clinical Studies Ivosidenib Oncology IDH1 Indications and Usage, Dosage and Administration, Clinical Pharmacology, Clinical Studies Ixabepilone (1) Oncology ERBB2
(HER2) Clinical Studies Ixabepilone (2) Oncology ESR, PGR
(Hormone Receptor) Clinical Studies Lacosamide Neurology CYP2C19 Clinical Pharmacology Lansoprazole Gastroenterology CYP2C19 Drug Interactions, Clinical Pharmacology Lapatinib (1) Oncology ERBB2
(HER2) Indications and Usage, Dosage and Administration, Adverse Reactions, Use in Specific Populations, Clinical Studies Lapatinib (2) Oncology ESR, PGR
(Hormone Receptor) Indications and Usage, Dosage and Administration, Adverse Reactions, Use in Specific Populations, Clinical Studies Lapatinib (3) Oncology HLA-DQA1 Clinical Pharmacology Lapatinib (4) Oncology HLA-DRB1 Clinical Pharmacology Larotrectinib Oncology NTRK Indications and Usage, Dosage and Administration, Adverse Reactions, Clinical Studies Lecanemab-irmb Neurology   APOE Boxed Warning, Warnings and Precautions, Clinical Studies, Patient Counseling Information Ledipasvir and Sofosbuvir Infectious Diseases IFNL3
(IL28B) Clinical Studies Lenalidomide Hematology Chromosome 5q Boxed Warning, Indications and Usage, Adverse Reactions, Use in Specific Populations, Clinical Studies Leniolisib (1) Pulmonary   PIK3CD Clinical Studies Leniolisib (2) Pulmonary   PIK3R1 Clinical Studies Lenvatinib Oncology Microsatellite Instability, Mismatch Repair Indications and Usage, Adverse Reactions, Clinical Studies Lesinurad Rheumatology CYP2C9 Drug Interactions, Clinical Pharmacology Letrozole Oncology ESR, PGR
(Hormone Receptor) Indications and Usage, Adverse Reactions, Clinical Studies Levothyroxine Endocrinology Nonspecific (Congenital Hypothyroidism) Indications and Usage, Warnings and Precautions, Use in Specific Populations Lidocaine and Prilocaine (1) Anesthesiology Nonspecific
(Congenital Methemoglobinemia) Warnings and Precautions Lidocaine and Prilocaine (2) Anesthesiology G6PD Warnings and Precautions, Clinical Pharmacology Lidocaine and Tetracaine (1) Anesthesiology G6PD Warnings and Precautions Lidocaine and Tetracaine (2) Anesthesiology Nonspecific
(Congenital Methemoglobinemia) Warnings and Precautions Lofexidine Anesthesiology CYP2D6 Use in Specific Populations Lomitapide Endocrinology Nonspecific
(Homozygous Familial Hypercholesterolemia) Indications and Usage, Warnings and Precautions, Adverse Reactions, Clinical Studies Lonafarnib (1) Inborn Errors of Metabolism LMNA Indications and Usage, Adverse Reactions, Use in Specific Populations, Clinical Studies Lonafarnib (2) Inborn Errors of Metabolism ZMPSTE24 Indications and Usage, Use in Specific Populations Lorlatinib (1) Oncology ALK Indications and Usage, Dosage and Administration, Adverse Reactions, Clinical Studies Lorlatinib (2) Oncology ROS1 Adverse Reactions Lumasiran Urology AGXT Indications and Usage, Adverse Reactions, Use in Specific Populations, Clinical Pharmacology, Clinical Studies Luspatercept–aamt Hematology HBB Clinical Studies Lusutrombopag (1) Hematology F2
(Prothrombin) Warnings and Precautions Lusutrombopag (2) Hematology F5
(Factor V Leiden) Warnings and Precautions Lusutrombopag (3) Hematology PROC Warnings and Precautions Lusutrombopag (4) Hematology PROS1 Warnings and Precautions Lusutrombopag (5) Hematology SERPINC1
(Antithrombin III) Warnings and Precautions Lutetium Lu 177 Dotatate Oncology SSTR Indications and Usage, Adverse Reactions, Use in Specific Populations, Clinical Pharmacology, Clinical Studies Lutetium Lu 177 Vipivotide Tetraxetan Oncology FOLH1
(PSMA) Indications and Usage, Dosage and Administration, Adverse Reactions, Clinical Studies Mafenide Infectious Diseases G6PD Warnings, Adverse Reactions Maralixibat (1) Gastroenterology JAG1 Clinical Studies Maralixibat (2) Gastroenterology ABCB4 Clinical Pharmacology, Clinical Studies Maralixibat (3) Gastroenterology ABCB11 Indications and Usage, Clinical Pharmacology, Clinical Studies Maralixibat (4) Gastroenterology ATP8B1 Clinical Pharmacology, Clinical Studies Maralixibat (5) Gastroenterology MYO5B Clinical Pharmacology, Clinical Studies Maralixibat (6) Gastroenterology TJP2 Clinical Pharmacology, Clinical Studies Margetuximab-cmkb (1) Oncology ERBB2
(HER2) Indications and Usage, Adverse Reactions, Clinical Pharmacology, Clinical Studies Margetuximab-cmkb (2) Oncology FCGR2A
(CD32A) Clinical Pharmacology Margetuximab-cmkb (3) Oncology FCGR2B
(CD32B) Clinical Pharmacology Margetuximab-cmkb (4) Oncology FCGR3A
(CD16A) Clinical Pharmacology Mavacamten Cardiology CYP2C19 Dosage and Administration, Clinical Pharmacology Mavorixafor Hematology CXCR4 Clinical Studies Mecasermin Endocrinology Nonspecific
(GH) Indications and Usage, Clinical Studies Meclizine Neurology CYP2D6 Warnings and Precautions Medroxyprogesterone Gynecology ESR
(Hormone Receptor) Warnings Meloxicam Anesthesiology CYP2C9 Use in Specific Populations, Clinical Pharmacology Mepivacaine (1) Anesthesiology G6PD Warnings Mepivacaine (2) Anesthesiology Nonspecific
(Congenital Methemoglobinemia) Warnings Mepolizumab Oncology   FIP1L1-PDGFRA   Adverse Reactions, Clinical Studies Mercaptopurine (1) Oncology TPMT Dosage and Administration, Warnings and Precautions, Adverse Reactions, Clinical Pharmacology Mercaptopurine (2) Oncology NUDT15 Dosage and Administration, Warnings and Precautions, Clinical Pharmacology Methylene Blue Hematology G6PD Contraindications, Warnings and Precautions Metoclopramide (1) Gastroenterology CYB5R Use in Specific Populations Metoclopramide (2) Gastroenterology G6PD Use in Specific Populations, Overdosage Metoclopramide (3) Gastroenterology CYP2D6 Dosage and Administration, Use in Specific Populations, Clinical Pharmacology Metoprolol Cardiology CYP2D6 Clinical Pharmacology Metreleptin Endocrinology LEP Contraindications Midostaurin (1) Oncology FLT3 Indications and Usage, Dosage and Administration, Adverse Reactions, Clinical Studies Midostaurin (2) Oncology NPM1 Clinical Studies Midostaurin (3) Oncology KIT Clinical Studies Migalastat Inborn Errors of Metabolism GLA Indications and Usage, Dosage and Administration, Clinical Pharmacology, Clinical Studies Mirabegron Urology CYP2D6 Clinical Pharmacology Mirvetuximab Soravtansine-gynx Oncology FOLR1 Indications and Usage, Dosage and Administration, Clinical Studies Mitapivat Hematology PKLR Clinical Studies Mivacurium Anesthesiology BCHE Warnings, Precautions, Clinical Pharmacology Mobocertinib Oncology EGFR Indications and Usage, Dosage and Administration, Adverse Reactions, Clinical Studies Modafinil Psychiatry CYP2D6 Clinical Pharmacology Mycophenolic Acid Transplantation HPRT1 Warnings and Precautions Nalidixic Acid Infectious Diseases G6PD Precautions, Adverse Reactions Nateglinide Endocrinology CYP2C9 Drug Interactions Nebivolol Cardiology CYP2D6 Dosage and Administration, Clinical Pharmacology Nedosiran Nephrology AGXT Indications and Usage, Adverse Reactions, Use in Specific Populations, Clinical Pharmacology, Clinical Studies Nefazodone Psychiatry CYP2D6 Precautions Neomycin Infectious Diseases   MT-RNR1   Warnings Neratinib (1) Oncology ERBB2
(HER2)

Indications and Usage, Adverse Reactions, Clinical Studies

Neratinib (2) Oncology ESR, PGR
(Hormone Receptor)

Clinical Studies

Nilotinib (1) Oncology BCR-ABL1
(Philadelphia chromosome) Indications and Usage, Dosage and Administration, Warnings and Precautions, Adverse Reactions, Use in Specific Populations, Clinical Pharmacology, Clinical Studies Nilotinib (2) Oncology UGT1A1 Clinical Pharmacology Niraparib Oncology BRCA (Homologous Recombination Deficiency) Indications and Usage, Dosage and Administration, Clinical Studies Nitrofurantoin Infectious Diseases G6PD Warnings, Adverse Reactions Nirogacestat (1) Oncology APC Clinical Studies Nirogacestat (2) Oncology CTNNB1 Clinical Studies Nivolumab (1) Oncology BRAF Adverse Reactions, Clinical Studies Nivolumab (2) Oncology CD274
(PD-L1) Indications and Usage, Dosage and Administration, Use in Specific Populations, Clinical Pharmacology, Clinical Studies Nivolumab (3) Oncology Microsatellite Instability, Mismatch Repair Indications and Usage, Clinical Studies Nivolumab (4) Oncology EGFR Indications and Usage, Adverse Reactions, Clinical Studies Nivolumab (5) Oncology ALK Indications and Usage, Adverse Reactions, Clinical Studies Nivolumab (6) Oncology ERBB2
(HER2) Adverse Reactions, Clinical Studies Nivolumab and Relatlimab-rmbw (1) Oncology BRAF Clinical Studies Nivolumab and Relatlimab-rmbw (2) Oncology CD274
(PD-L1) Clinical Studies Nivolumab and Relatlimab-rmbw (3) Oncology LAG3 Clinical Studies Nortriptyline Psychiatry CYP2D6 Precautions Nusinersen Neurology SMN2 Clinical Pharmacology, Clinical Studies Obinutuzumab Oncology MS4A1
(CD20 antigen) Clinical Studies Odevixibat (1) Gastroenterology ABCB11 Indications and Usage, Clinical Pharmacology, Clinical Studies Odevixibat (2)
Gastroenterology ATP8B1 Indications and Usage, Clinical Pharmacology, Clinical Studies Odevixibat (3) Gastroenterology JAG1 Clinical Studies Odevixibat (4) Gastroenterology NOTCH2 Clinical Studies Olaparib (1) Oncology BRCA Indications and Usage, Dosage and Administration, Warnings and Precautions, Adverse Reactions, Clinical Studies Olaparib (2) Oncology ERBB2
(HER2) Indications and Usage, Dosage and Administration, Adverse Reactions, Clinical Studies Olaparib (3) Oncology ESR, PGR
(Hormone Receptor)

Indications and Usage, Clinical Studies

Olaparib (4) Oncology BRCA, Genomic Instability (Homologous Recombination Deficiency) Indications and Usage, Dosage and Administration, Adverse Reactions, Clinical Studies Olaparib (5) Oncology Homologous Recombination Repair Indications and Usage, Dosage and Administration, Adverse Reactions, Clinical Studies Olaparib (6) Oncology PPP2R2A Clinical Studies Olaratumab Oncology PDGFRA Clinical Studies Oliceridine Anesthesiology CYP2D6 Warnings and Precautions, Drug Interactions, Use in Specific Populations, Clinical Pharmacology Olutasidenib Oncology IDH1 Indications and Usage, Dosage and Administration, Adverse Reactions, Use in Specific Populations, Clinical Pharmacology, Clinical Studies Omacetaxine Oncology BCR-ABL1
(Philadelphia chromosome) Clinical Studies Ombitasvir, Paritaprevir, and Ritonavir Infectious Diseases IFNL3
(IL28B) Clinical Studies Omeprazole Gastroenterology CYP2C19 Drug Interactions, Clinical Pharmacology Oxymetazoline and Tetracaine (1) Anesthesiology G6PD Warnings and Precautions Oxymetazoline and Tetracaine (2) Anesthesiology Nonspecific
(Congenital Methemoglobinemia) Warnings and Precautions Ondansetron Gastroenterology CYP2D6 Clinical Pharmacology Osimertinib Oncology EGFR Indications and Usage, Dosage and Administration, Adverse Reactions, Use in Specific Populations, Clinical Studies Ospemifene (1) Gynecology CYP2C9 Clinical Pharmacology Ospemifene (2) Gynecology CYP2B6 Clinical Pharmacology Oxcarbazepine Neurology HLA-B Warnings and Precautions Palbociclib (1) Oncology ESR
(Hormone Receptor) Indications and Usage, Adverse Reactions, Clinical Studies Palbociclib (2) Oncology ERBB2
(HER2) Indications and Usage, Adverse Reactions, Clinical Studies Paliperidone Psychiatry CYP2D6 Clinical Pharmacology Palonosetron Gastroenterology CYP2D6 Clinical Pharmacology Panitumumab (1) Oncology EGFR Adverse Reactions, Clinical Pharmacology, Clinical Studies Panitumumab (2) Oncology RAS Indications and Usage, Dosage and Administration, Warnings and Precautions, Adverse Reactions, Clinical Studies Pantoprazole Gastroenterology CYP2C19 Clinical Pharmacology Parathyroid Hormone Inborn Errors of Metabolism CASR Indications and Usage, Clinical Studies Paroxetine Psychiatry CYP2D6 Drug Interactions, Clinical Pharmacology Patisiran Neurology TTR Adverse Reactions, Clinical Pharmacology, Clinical Studies Pazopanib (1) Oncology UGT1A1 Clinical Pharmacology Pazopanib (2) Oncology HLA-B Clinical Pharmacology Peginterferon Alfa-2b Infectious Diseases IFNL3
(IL28B) Clinical Pharmacology Pegloticase Rheumatology G6PD Boxed Warning, Contraindications, Warnings and Precautions, Adverse Reactions, Patient Counseling Information Pembrolizumab (1) Oncology BRAF Adverse Reactions, Clinical Studies Pembrolizumab (2) Oncology CD274
(PD-L1) Indications and Usage, Dosage and Administration, Adverse Reactions, Use in Specific Populations, Clinical Studies Pembrolizumab (3) Oncology Microsatellite Instability, Mismatch Repair Indications and Usage, Dosage and Administration, Adverse Reactions, Use in Specific Populations, Clinical Studies Pembrolizumab (4) Oncology EGFR Indications and Usage, Adverse Reactions, Clinical Studies Pembrolizumab (5) Oncology ALK Indications and Usage, Adverse Reactions, Clinical Studies Pembrolizumab (6) Oncology Tumor Mutational Burden Indications and Usage, Dosage and Administration, Use in Specific Populations, Clinical Studies Pembrolizumab (7) Oncology ERBB2
(HER2) Indications and Usage, Adverse Reactions, Clinical Studies Pemetrexed (1) Oncology ALK Indications and Usage, Adverse Reactions, Clinical Studies Pemetrexed (2) Oncology EGFR Indications and Usage, Adverse Reactions, Clinical Studies Pemetrexed (3) Oncology CD274
(PD-L1) Clinical Studies Pemigatinib (1) Oncology FGFR1 Indications and Usage, Dosage and Administration, Adverse Reactions, Use in Specific Populations, Clinical Studies Pemigatinib (2) Oncology FGFR2 Indications and Usage, Dosage and Administration, Clinical Studies Perphenazine Psychiatry CYP2D6 Precautions, Clinical Pharmacology Pertuzumab (1) Oncology ERBB2
(HER2) Indications and Usage, Dosage and Administration, Warnings and Precautions, Adverse Reactions, Clinical Pharmacology, Clinical Studies Pertuzumab (2) Oncology ESR, PGR
(Hormone Receptor) Clinical Studies Phenytoin (1) Neurology CYP2C9 Warnings and Precautions, Use in Specific Populations, Clinical Pharmacology Phenytoin (2) Neurology CYP2C19 Clinical Pharmacology Phenytoin (3) Neurology HLA-B Warnings and Precautions Pimozide Psychiatry CYP2D6 Dosage and Administration, Precautions Piroxicam Rheumatology CYP2C9 Clinical Pharmacology Pirtobrutinib (1) Oncology BTK Clinical Studies Pirtobrutinib (2) Oncology Chromosome 11q Clinical Studies Pirtobrutinib (3) Oncology Chromosome 17p Clinical Studies Pirtobrutinib (4) Oncology IGHV Clinical Studies Pirtobrutinib (5) Oncology TP53 Clinical Studies Pitavastatin Endocrinology Nonspecific
(Heterozygous Familial Hypercholesterolemia)

Indications and Usage, Adverse Reactions, Use in Specific Populations, Clinical Studies

Pitolisant Psychiatry CYP2D6 Dosage and Administration, Use in Specific Populations, Clinical Pharmacology Plazomicin Infectious Diseases   MT-RNR1   Warnings and Precautions Polatuzumab Vedotin-piiq (1) Oncology   BCL2   Clinical Studies Polatuzumab Vedotin-piiq (2) Oncology   BCL6   Clinical Studies Polatuzumab Vedotin-piiq (3) Oncology   MYC   Clinical Studies Ponatinib Oncology BCR-ABL1
(Philadelphia chromosome) Indications and Usage, Dosage and Administration, Warnings and Precautions, Adverse Reactions, Use in Specific Populations, Clinical Studies Pralsetinib Oncology CCDC6-RET, KIF5B-RET, RET Indications and Usage, Dosage and Administration, Adverse Reactions, Use in Specific Populations, Clinical Pharmacology, Clinical Studies Prasugrel (1) Cardiology CYP2C19 Use in Specific Populations, Clinical Pharmacology, Clinical Studies Prasugrel (2) Cardiology CYP2C9 Use in Specific Populations, Clinical Pharmacology, Clinical Studies Prasugrel (3) Cardiology CYP3A5 Use in Specific Populations, Clinical Pharmacology, Clinical Studies Prasugrel (4) Cardiology CYP2B6 Use in Specific Populations, Clinical Pharmacology, Clinical Studies Primaquine (1) Infectious Diseases G6PD Contraindications, Warnings, Precautions, Adverse Reactions, Overdosage Primaquine (2) Infectious Diseases CYB5R Precautions, Adverse Reactions Probenecid Rheumatology G6PD Adverse Reactions Procainamide Cardiology Nonspecific
(NAT) Adverse Reactions, Clinical Pharmacology Propafenone Cardiology CYP2D6 Dosage and Administration, Warnings and Precautions, Drug Interactions, Clinical Pharmacology Propranolol Cardiology CYP2D6 Clinical Pharmacology Protriptyline Psychiatry CYP2D6 Precautions Quinidine Cardiology CYP2D6 Precautions Quinine Sulfate (1) Infectious Diseases G6PD Warnings and Precautions Quinine Sulfate (2) Infectious Diseases CYP2D6 Clinical Pharmacology Quizartinib Oncology FLT3 Indications and Usage, Dosage and Administration, Warnings and Precautions, Adverse Reactions, Clinical Studies Rabeprazole Gastroenterology CYP2C19 Drug Interactions, Clinical Pharmacology Raloxifene Oncology ESR
(Hormone Receptor) Clinical Studies Raltegravir Infectious Diseases UGT1A1 Clinical Pharmacology Ramucirumab (1) Oncology EGFR Indications and Usage, Dosage and Administration, Adverse Reactions, Clinical Studies Ramucirumab (2) Oncology RAS Clinical Studies Rasburicase (1) Oncology G6PD Boxed Warning, Contraindications, Warnings and Precautions Rasburicase (2) Oncology CYB5R Boxed Warning, Contraindications, Warnings and Precautions Ravulizumab-cwvz (1) Neurology ACHR Indications and Usage, Clinical Studies Ravulizumab-cwvz (2) Neurology AQP4 Indications and Usage, Clinical Studies Regorafenib Oncology RAS Indications and Usage, Clinical Studies Repotrectinib (1) Oncology ROS1 Indications and Usage, Dosage and Administration, Adverse Reactions, Use in Specific Populations, Clinical Studies Repotrectinib (2) Oncology NTRK Indications and Usage, Dosage and Administration, Adverse Reactions, Use in Specific Populations, Clinical Studies Resmetirom Gastroenterology ABCG2 Clinical Pharmacology Ribociclib (1) Oncology ESR, PGR (Hormone Receptor) Indications and Usage, Adverse Reactions, Clinical Studies Ribociclib (2) Oncology ERBB2
(HER2) Indications and Usage, Adverse Reactions, Clinical Studies Rimegepant Neurology CYP2C9 Clinical Pharmacology Risdiplam Neurology SMN1, SMN2 Clinical Studies Risperidone Psychiatry CYP2D6 Clinical Pharmacology Rituximab Oncology MS4A1
(CD20 antigen) Indications and Usage, Dosage and Administration, Adverse Reactions, Use in Specific Populations, Clinical Studies Rivaroxaban Cardiology F5
(Factor V Leiden) Clinical Studies Ropeginterferon Alfa-2b-njft Hematology JAK2 Clinical Pharmacology, Clinical Studies Ropivacaine (1) Anesthesiology G6PD Warnings Ropivacaine (2) Anesthesiology Nonspecific
(Congenital Methemoglobinemia) Warnings Rosuvastatin Endocrinology SLCO1B1 Clinical Pharmacology Rozanolixizumab-noli (1) Neurology   ACHR Indications and Usage, Clinical Pharmacology, Clinical Studies Rozanolixizumab-noli (2) Neurology   MUSK   Indications and Usage, Clinical Pharmacology, Clinical Studies Rucaparib (1) Oncology BRCA Indications and Usage, Dosage and Administration, Adverse Reactions, Clinical Studies Rucaparib (2) Oncology CYP2D6 Clinical Pharmacology Rucaparib (3) Oncology CYP1A2 Clinical Pharmacology Rucaparib (4) Oncology BRCA, Loss of Heterozygosity (Homologous Recombination Deficiency) Warnings and Precautions, Adverse Reactions, Clinical Studies Sacituzumab Govitecan-hziy (1) Oncology UGT1A1 Warnings and Precautions, Clinical Pharmacology Sacituzumab Govitecan-hziy (2) Oncology   BRCA   Clinical Studies Sacituzumab Govitecan-hziy (3) Oncology   ESR
(Hormone Receptor)   Indications and Usage, Adverse Reactions, Use in Specific Populations, Clinical Studies Sacituzumab Govitecan-hziy (4) Oncology   ERBB2
(HER2)   Indications and Usage, Adverse Reactions, Use in Specific Populations, Clinical Studies Sacrosidase Inborn Errors of Metabolism Nonspecific
(Congenital Sucrase-Isomaltase Deficiency) Indications and Usage, Adverse Reactions, Clinical Pharmacology Satralizumab-mwge Neurology AQP4 Indications and Usage, Adverse Reactions, Clinical Studies Selpercatinib Oncology RET Indications and Usage, Dosage and Administration, Adverse Reactions, Use in Specific Populations, Clinical Studies Setmelanotide (1) Endocrinology LEPR Indications and Usage, Dosage and Administration, Adverse Reactions, Use in Specific Populations, Clinical Studies Setmelanotide (2) Endocrinology PCSK1 Indications and Usage, Dosage and Administration, Adverse Reactions, Use in Specific Populations, Clinical Studies Setmelanotide (3) Endocrinology POMC Indications and Usage, Dosage and Administration, Adverse Reactions, Use in Specific Populations, Clinical Studies Sevoflurane Anesthesiology CACNA1S, RYR1
(Genetic Susceptibility to Malignant Hyperthermia) Contraindications, Warnings, Clinical Pharmacology Simeprevir Infectious Diseases IFNL3
(IL28B) Clinical Pharmacology, Clinical Studies Siponimod Neurology CYP2C9 Dosage and Administration, Contraindications, Drug Interactions, Use in Specific Populations, Clinical Pharmacology Sodium Nitrite (1) Toxicology G6PD Warnings and Precautions Sodium Nitrite (2) Toxicology Nonspecific
(Congenital Methemoglobinemia) Boxed Warning, Warnings and Precautions Sodium Oxybate Neurology ALDH5A1
(Succinic Semialdehyde Dehydrogenase Deficiency) Contraindications Sodium Phenylbutyrate Inborn Errors of Metabolism ASS1, CPS1, OTC
(Urea Cycle Disorders) Indications and Usage, Dosage and Administration, Adverse Reactions, Clinical Pharmacology Sofosbuvir Infectious Diseases IFNL3
(IL28B) Clinical Studies Sofosbuvir and Velpatasvir Infectious Diseases IFNL3
(IL28B) Clinical Studies Sofosbuvir, Velpatasvir, and Voxilaprevir Infectious Diseases IFNL3
(IL28B) Clinical Studies Sotorasib Oncology KRAS Indication and Usage, Dosage and Administration, Adverse Reactions, Clinical Pharmacology, Clinical Studies Streptomycin Infectious Diseases   MT-RNR1   Warnings Succimer Hematology G6PD Clinical Pharmacology Succinylcholine (1) Anesthesiology BCHE Warnings, Precautions Succinylcholine (2) Anesthesiology

CACNA1S, RYR1
(Genetic Susceptibility to Malignant Hyperthermia)

Boxed Warning, Contraindications, Warnings, Precautions, Adverse Reactions, Clinical Pharmacology Sulfadiazine Infectious Diseases G6PD Warnings Sulfamethoxazole and Trimethoprim (1) Infectious Diseases G6PD Precautions Sulfamethoxazole and Trimethoprim (2) Infectious Diseases Nonspecific
(NAT) Precautions Sulfasalazine (1) Gastroenterology G6PD Precautions Sulfasalazine (2) Gastroenterology Nonspecific
(NAT) Clinical Pharmacology Synthetic Conjugated Estrogens, A (1) Gynecology PROC Contraindications Synthetic Conjugated Estrogens, A (2) Gynecology PROS1 Contraindications Synthetic Conjugated Estrogens, A (3) Gynecology SERPINC1
(Antithrombin III) Contraindications Tafamidis Cardiology TTR Clinical Pharmacology, Clinical Studies Tafenoquine Infectious Diseases G6PD Dosage and Administration, Contraindications, Warnings and Precautions, Use in Specific Populations, Patient Counseling Information Talazoparib (1) Oncology BRCA Indications and Usage, Dosage and Administration, Adverse Reactions, Clinical Studies Talazoparib (2) Oncology ERBB2
(HER2) Indications and Usage, Adverse Reactions, Clinical Studies Talazoparib (3) Oncology
Homologous Recombination Repair   Indications and Usage, Dosage and Administrations, Adverse Reactions, Drug Interactions, Clinical Studies Tamoxifen (1) Oncology ESR, PGR
(Hormone Receptor) Indications and Usage, Adverse Reactions, Clinical Pharmacology, Clinical Studies Tamoxifen (2) Oncology F5
(Factor V Leiden) Warnings and Precautions Tamoxifen (3) Oncology F2
(Prothrombin) Warnings and Precautions Tamoxifen (4) Oncology CYP2D6 Clinical Pharmacology Tamsulosin Urology CYP2D6 Warnings and Precautions, Adverse Interactions, Clinical Pharmacology Tebentafusp-tebn Oncology HLA-A Indications and Usage, Dosage and Administration, Clinical Studies Teclistamab-cqyv (1) Oncology Chromosome 17p Clinical Studies Teclistamab-cqyv (2) Oncology Chromosome 4p;14q Clinical Studies Teclistamab-cqyv (3) Oncology Chromosome 14q;16q Clinical Studies Telaprevir Infectious Diseases IFNL3
(IL28B) Clinical Pharmacology, Clinical Studies Tepotinib (1) Oncology ALK Clinical Studies Tepotinib (2) Oncology EGFR Clinical Studies Tepotinib (3) Oncology MET Indications and Usage, Dosage and Administration, Adverse Reactions, Use in Specific Populations, Clinical Studies Tetrabenazine Neurology CYP2D6 Dosage and Administration, Warnings and Precautions, Use in Specific Populations, Clinical Pharmacology Thioguanine (1) Oncology TPMT Dosage and Administration, Warnings, Precautions, Clinical Pharmacology Thioguanine (2) Oncology NUDT15 Dosage and Administration, Warnings, Precautions, Clinical Pharmacology Thioridazine Psychiatry CYP2D6 Contraindications, Warnings, Precautions Ticagrelor Cardiology CYP2C19 Clinical Pharmacology Tipiracil and Trifluridine (1) Oncology ERBB2
(HER2) Indications and Usage, Adverse Reactions, Clinical Studies Tipiracil and Trifluridine (2) Oncology RAS Indications and Usage, Clinical Studies Tislelizumab-jsgr Oncology CD274
(PD-L1) Clinical Studies Tobramycin Infectious Diseases   MT-RNR1   Warnings and Precautions Tofersen Oncology   SOD1 Indications and Usage, Use in Specific Populations, Clinical Studies Tolazamide Endocrinology G6PD Precautions Tolbutamide Endocrinology G6PD Precautions Tolterodine Urology CYP2D6 Warnings and Precautions, Drug Interactions, Clinical Pharmacology Toremifene Oncology ESR
(Hormone Receptor) Indications and Usage, Clinical Studies Tovorafenib Oncology BRAF Indications and Usage, Dosage and Administration, Warnings and Precautions, Adverse Reactions, Use in Specific Populations, Clinical Studies Tramadol Anesthesiology CYP2D6 Boxed Warning, Warnings and Precautions, Use in Specific Populations, Clinical Pharmacology, Patient Counseling Information Trametinib (1) Oncology BRAF Indications and Usage, Dosage and Administration, Adverse Reactions, Use in Specific Populations, Clinical Pharmacology, Clinical Studies Trametinib (2) Oncology G6PD Adverse Reactions Trametinib (3) Oncology RAS Warnings and Precautions Trastuzumab (1) Oncology ERBB2
(HER2) Indications and Usage, Dosage and Administration, Clinical Pharmacology, Clinical Studies Trastuzumab (2) Oncology ESR, PGR
(Hormone Receptor) Clinical Studies Tretinoin Oncology PML-RARA Indications and Usage, Dosage and Administration, Warnings and Precautions, Patient Counseling Information Triheptanoin Inborn Errors of Metabolism ACADVL, CPT2, HADHA, HADHB (Long-Chain Fatty Acid Oxidation Disorders) Indications and Usage, Clinical Studies Tremelimumab-actl (1) Oncology ALK Indications and Usage, Clinical Studies Tremelimumab-actl (2) Oncology EGFR Indications and Usage, Clinical Studies Tremelimumab-actl (3) Oncology CD274
(PD-L1) Clinical Studies Trimipramine Psychiatry CYP2D6 Precautions Trofinetide Neurology   MECP2 Clinical Studies Tucatinib (1) Oncology ERBB2
(HER2) Indications and Usage, Dosage and Administration, Adverse Reactions, Clinical Studies Tucatinib (2) Oncology Microsatellite Instability, Mismatch Repair   Indications and Usage, Dosage and Administration, Adverse Reactions, Clinical Studies Tucatinib (3) Oncology   RAS   Clinical Studies Umeclidinium Pulmonary CYP2D6 Clinical Pharmacology Upadacitinib Rheumatology CYP2D6 Clinical Pharmacology Ustekinumab Dermatology and Gastroenterology IL12A, IL12B, IL23A Warnings and Precautions Valbenazine Neurology CYP2D6 Dosage and Administration, Warnings and Precautions, Use in Specific Populations, Clinical Pharmacology Valproic Acid (1) Neurology POLG Boxed Warning, Contraindications, Warnings and Precautions Valproic Acid (2) Neurology Nonspecific
(Urea Cycle Disorders) Contraindications, Warnings and Precautions Vemurafenib (1) Oncology BRAF Indications and Usage, Dosage and Administration, Warnings and Precautions, Adverse Reactions, Use in Specific Populations, Clinical Pharmacology, Clinical Studies, Patient Counseling Information Vemurafenib (2) Oncology RAS Warnings and Precautions, Adverse Reactions Venetoclax (1) Oncology Chromosome 17p Clinical Studies Venetoclax (2) Oncology Chromosome 11q Clinical Studies Venetoclax (3) Oncology TP53 Clinical Studies Venetoclax (4) Oncology IDH1 Clinical Studies Venetoclax (5) Oncology IDH2 Clinical Studies Venetoclax (6) Oncology IGHV Clinical Studies Venetoclax (7) Oncology NPM1 Clinical Studies Venetoclax (8) Oncology FLT3 Clinical Studies Venlafaxine Psychiatry CYP2D6 Drug Interactions, Use in Specific Populations, Clinical Pharmacology Viloxazine (1) Psychiatry CYP2D6 Clinical Pharmacology Viloxazine (2) Psychiatry SLCO1B1 Clinical Pharmacology Viltolarsen Neurology DMD Indications and Usage, Adverse Reactions, Use in Specific Populations, Clinical Pharmacology, Clinical Studies Vincristine Oncology BCR-ABL1
(Philadelphia chromosome) Indications and Usage, Adverse Reactions, Clinical Studies Voriconazole Infectious Diseases CYP2C19 Clinical Pharmacology Vortioxetine Psychiatry CYP2D6 Dosage and Administration, Clinical Pharmacology Voxelotor Hematology HBB Clinical Pharmacology, Clinical Studies Vutrisiran Neurology TTR Adverse Reactions, Clinical Pharmacology, Clinical Studies Warfarin (1) Hematology CYP2C9 Dosage and Administration, Drug Interactions, Clinical Pharmacology Warfarin (2) Hematology VKORC1 Dosage and Administration, Clinical Pharmacology Warfarin (3) Hematology PROS1 Warnings and Precautions Warfarin (4) Hematology PROC Warnings and Precautions Zanubrutinib (1) Oncology MYD88 Adverse Reactions, Clinical Studies Zanubrutinib (2) Oncology   Chromosome 17p   Adverse Reactions, Clinical Studies Zanubrutinib (3) Oncology   TP53   Clinical Studies Zilucoplan Neurology ACHR Indications and Usage, Clinical Studies

Source